DELLAVEDOVA, GIULIA
DELLAVEDOVA, GIULIA
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Mostra
records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.011 secondi).
The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer
2021 Dellavedova, G; Decio, A; Staniszewska, A; Leo, E; Giavazzi, R; Bani, M
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases
2022 Anastasia, A; Dellavedova, G; Ramos-Montoya, A; James, N; Chiorino, G; Russo, M; Baakza, H; Wilson, J; Ghilardi, C; Cadogan, E; Giavazzi, R; Rosa Bani, M
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin
2023 Dellavedova, G; Decio, A; Formenti, L; Albertella, M; Wilson, J; Staniszewska, A; Leo, E; Giavazzi, R; Ghilardi, C; Rosa Bani, M
STRATEGIES TO OVERCOME OLAPARIB DRAWBACKS: FROM PATIENT SELECTION TO NOVEL THERAPIES
2024 Dellavedova, G
| Titolo | Tipologia | Data di pubblicazione | Autori | File |
|---|---|---|---|---|
| The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer | 02 - Intervento a convegno | 2021 | Dellavedova, G + | |
| The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases | 01 - Articolo su rivista | 2022 | Giulia Dellavedova + | |
| The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin | 01 - Articolo su rivista | 2023 | Giulia DellavedovaLaura Formenti + | |
| STRATEGIES TO OVERCOME OLAPARIB DRAWBACKS: FROM PATIENT SELECTION TO NOVEL THERAPIES | 07 - Tesi di dottorato Bicocca post 2009 | 2024 | DELLAVEDOVA, GIULIA |